| Objective This study investigated the intervention of CKG drug-containing serum on miR-545-3p-mediated osteolipid differentiation in hBMSCs via smad4, aiming to clarify the decisive role of miR-545-3p in determining hBMSC differentiation fate. Methods Bioinformatics analysis identified a binding site between miR-545-3p and smad4, which was confirmed by a dual-luciferase assay to be a targeting relationship. The hBMSCs were allocated to a control group, a negative control (NC inhibitor/mimic) group, a miR-545-3p inhibitor/mimic transfection group, and several CKG drug-containing serum intervention groups: a blank serum group, a drug-containing serum group, a drug-containing serum +oeNC group, and a drug-containing serum +oemiR-545-3p group. The expression levels of miR-545-3p, Smad4, and osteogenic (RUNX2, ALP, OCN) or adipogenic (PPARγ, FABP4) markers were quantified using qPCR and Western blot. Osteogenic and adipogenic differentiation were assessed via ALP staining, Alizarin Red S staining, and Oil Red O staining, respectively. Results The dual-luciferase assay confirmed that miR-545-3p targets smad4 and inhibits its function. Overexpression of miR-545-3p suppressed Smad4 gene and protein expression (***P<0.001) and impeded its nuclear translocation. This overexpression also reduced the protein and gene levels of ALP, RUNX2, and OCN (****P<0.0001), decreased the formation of calcium nodules and their positive area (***P<0.001), and increased the protein, gene, and lipid accumulation of PPARγ and FABP4 (****P<0.0001). CKG drug-containing serum inhibited miR-545-3p expression (****P<0.0001), enhanced smad4 protein levels and its nuclear entry, promoted osteogenic differentiation of hBMSCs, and suppressed adipocyte transformation. Exogenous overexpression of miR-545-3p partially reversed the effect of CKG drug-containing serum on regulating the osteolipid differentiation balance in hBMSCs. Conclusion CKG drug-containing serum promotes osteogenic differentiation and inhibits adipogenic differentiation in hBMSCs by suppressing miR-545-3p expression and facilitating the nuclear translocation of Smad4. |